Manifestaciones neurológicas periféricas en la infección por Sars-CoV-2: enfoque desde la Medicina Física y la Rehabilitación
DOI:
https://doi.org/10.28957/rcmfr.v30spa6Palabras clave:
Coronavirus, Covid-19, Sars-CoV-2, nervios periféricos, lesiones de nervios periféricos, rehabilitaciónResumen
Desde su notificación a finales del 2019, la infección secundaria a coronavirus se ha difundido a nivel global hasta sercalificada como una pandemia. La respuesta inflamatoria generalizada que produce la infección por Sars-CoV-2, compromete múltiples órganos y sistemas, siendo el sistema respiratorio uno de los más afectados y con desenlace fatal, sin embargo, la afectación del sistema nervioso periférico puede implicar el desarrollo de déficits permanentes,con limitaciones en las actividades de la vida diaria yrestricción en la participación, llevando a la pérdida de independencia yreducción de la calidad de vida. El médico rehabilitador debe estar enfocado al reconocimiento y detección temprana de la patología nerviosa periférica, así como a determinar la intervención de la cual se beneficia más el paciente, liderar el equipo interdisciplinario de salud y mantener un trabajo fluido con otras especialidades médicas.
Referencias bibliográficas
1. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China - Key questions for impact assessment. N Engl J Med. 2020; 382:692-694. Disponible en: http://doi.org/10.1056/NEJMp2000929
2. Organización Panamericana de la Salud [OPS] - Organización Mundial de la Salud [OMS]. Actualización epidemiológica: Enfermedad por coronavirus (Covid-19) - 26 de agosto de 2020 [Internet]. 2020 [citado 2020 junio 2020]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-enfermedad-porcoronavirus-covid-19-26-agosto-2020
3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (Covid19) outbreak. J Autoimmun. 2020;109:102433. Disponible en: http://doi.org/10.1016/j.jaut.2020.102433
4. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020;133(9):1015-1024. Disponible en: https://doi.org/10.1097/CM9.0000000000000722
5 Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (Covid-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. Disponible en: https://doi.org/10.1186/s40249-020-00646-xh
6. Yuki K, Fujiogi M, Koutsogiannaki S. Covid-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. Disponible en: https://doi.org/10.1016/j.clim.2020.108427
7. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T et al. The epidemiology and clinical information about Covid-19. Eur J Clin Microbiol Infect Dis. 2020; 39:1011-1019. Disponible en: https://doi.org/10.1007/s10096-020-03874-zht
8. World Health Organization [WHO]. WHO Coronavirus disease (Covid-19) dashboard [Internet]. 2020. [citado 2020 junio 21]. Disponible en: https://covid19.who.int
9. Tindale LC, Stockdale JE, Coombe M, Garlock ES, Yin W, Lau V et al. Evidence for transmission of Covid-19 priorto symptomonset. eLife. 2020;9:e57149.
Disponible en: https://doi.org/10.7554/eLife.57149ht
10. Zhang Y, Muscatello D, Tian Y, Chen Y, Li S, Duan W et al. Role of presymptomatic transmission of Covid-19: evidence from Beijing, China. J Epidemiol Community Health. 2020;0:1-4. Disponible en: https://doi.org/10.1136/jech-2020-214635
11. Viego V, Geri M, Castiglia J, Jouglard E. Período de incubación e intervalo serial para Covid-19 en una cadena de transmisión en Bahía Blanca (Argentina). Ciên Saúde Coletiva. 2020;25(9):3503-3510. Disponible en: https://doi.org/10.1590/1413-81232020259.20852020
12. Nikolai LA, Meyer CG, Kremsner PG, Velavan TP. Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible. Int J Infect Dis. 2020;100:112-116. Disponible en: https://doi.org/10.1016/j.ijid.2020.08.076ht
13. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H et al. An overview of Covid-19. J Zhejiang Univ Sci B. 2020;21:343-360. Disponible en: https://doi.org/10.1631/jzus.B2000083
14. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W et al. Virology, epidemiology, pathogenesis, and control of Covid-19. Viruses. 2020;12(4):372. Disponible en: https://doi.org/10.3390/v12040372
15. Vaninov N. In the eye of the Covid-19 cytokine storm. Nat Rev Immunol 2020;20:277. Disponible en: https://doi.org/10.1038/s41577-020-0305-6
16. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell infection and endotheliitis in Covid-19. Lancet. 2020;395(10234):1417-1418. Disponible en: https://doi.org/10.1016/S0140-6736(20)30937-5h
17. Cecconi M, Forni G, Mantovani A. Ten things we learned about Covid-19. Intensive Care Med. 2020;46:1590-1593. Disponible en: https://doi.org/10.1007/s00134-020-06140-0
18. Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini P et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the Covid-19 pandemic. J Neurol Sci. 2020;417:117085. Disponible en: https://doi.org/10.1016/j.jns.2020.117085
19. Javed B, Sarver A, Soto EB, Mashwani Z. The coronavirus (Covid-19) pandemic’s impacton mental health. Int J Health Plann Manage. 2020; 35(5):993-996. Disponible en: https://doi.org/10.1002/hpm.3008ht
20. Payus AO, Liew Sat Lin C, Mohd Noh M, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (Covid-19). Bosn J Basic Med Sci. 2020;20(3):283-292. Disponible en: https://doi.org/10.17305/bjbms.2020.4860
21. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F et al. Covid-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. Disponible en: https://doi.org/10.1111/joim.13091h
22. Lahiri D, Ardila A. Covid-19 Pandemic: A Neurological Perspective. Cureus. 2020;12(4): e7889. Disponible en: https://doi.org/10.7759/cureus.7889
23. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Disponible en: https://doi.org/10.1001/jamaneurol.2020.1127
24. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM et al. The neurology of Covid19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. Disponible en: https://doi.org/10.1016/j.jns.2020.116884
25. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2:
from neurological manifestations of Covid-19 to potential neurotropic mechanisms. J Neurol. 2020;267:2179-2184. Disponible en: https://doi.org/10.1007/s00415-020-09929-7
26. McNeary L, Maltser S, Verduzco-Gutierrez M. Navigating Coronavirus Disease 2019 (Covid-19) in Physiatry: A CAN Report for Inpatient Rehabilitation Facilities. PM&R. 2020;12(5): 512-515. Disponible en: https://doi.org/10.1002/pmrj.12369
27. Carda S, Invernizzi M, Bavikatte G, Bensmaïl D, Bianchi F, Deltombe T et al. Covid-19 pandemic. What should PRM specialists do? A clinician’s perspective. Eur J Phys Rehabil Med. 2020;56(4):515-524. Disponible en: https://doi.org/10.23736/S1973-9087.20.06317-0
28. Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T et al. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20:e00771. Disponible en:
https://doi.org/10.1016/j.idcr.2020.e00771ht
29. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-384. Disponible en: https://doi.org/10.1016/S1474-4422(20)30109-5ht
30. Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (Covid-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41:1351-1354. Disponible en: https://doi.org/10.1007/s10072-020-04449-8
31. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. Covid-19 may induce Guillain–Barré syndrome. Rev Neurol (Paris). 2020;176(6):516-518. Disponible en: https://doi.org/10.1016/j.neurol.2020.04.003ht
32. Sedaghat Z, Karimi N. Guillain-Barré syndrome associated with Covid-19 infection: A case report. J Clin Neurosci. 2020;76:233-235. Disponible en: https://doi.org/10.1016/j.jocn.2020.04.062
33. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARSCoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Sys. 2020;25:204- 207. Disponible en: https://doi.org/10.1111/jns.12382
34. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, GordoMañas R et al. Miller Fisher Syndrome and polyneuritis cranialis in Covid-19. Neurology. 2020;95(5):e607-e605. Disponible en: https://doi.org/10.1212/WNL.0000000000009619
35. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. Covid-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020; 95(5):221-223. Disponible en: https://doi.org/10.1212/WNL.0000000000009700
36. De Freitas Ferreira ACA, Romão TT, SIlva Macedo Y, Pupe C, Nascimento OJM. COVID?19 and herpes zoster co?infection presenting with trigeminal neuropathy. Eur J Neurol. 2020;27(9):1748- 1750. Disponible en: https://doi.org/10.1111/ene.14361
37. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. Disponible en: https://doi.org/10.1016/S0140-6736(20)30183-5ht
38. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. Disponible en: https://doi.org/10.1001/jama.2020.1585
39. Alexrescu R, Siegert RJ, Turner-Stokes L. Functional outcomes and efficiency of rehabilitation in a national cohort of patients with Guillain - Barré syndrome and other inf lammator y polyneuropathies. PLoS One. 2014; 9(11):e110532. Disponible en: https://doi.org/10.1371/journal.pone.0110532
40. Sheehy LM. Considerations for postacute rehabilitation for survivors of Covid-19. JMIR Public Health Surveill. 2020;6(2):e19462. Disponible en: https://doi.org/10.2196/19462
41. Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S et al. The Stanford Hall consensus statement for post-Covid-19 rehabilitation. Br J Sports Med. 2020; 54:949-959. Disponible en: https://doi.org/10.1136/bjsports-2020-102596
42. Turner-Stokes L, Vanderstay R, Stevermuer T, Simmonds F, Khan F, Eagar K. Comparison of rehabilitation outcomes for long term neurological conditions: A cohort analysis of the Australian rehabilitation outcomes centre dataset for adults of working age. PLoS One. 2015;10(7):e0132275. Disponible en: https://doi.org/10.1371/journal.pone.0132275
43. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15:671– 683. Disponible en: https://doi.org/10.1038/s41582-019-0250-9
44. Corrado B, Ciardi G, Bargigli C. Rehabilitation Management of the Charcot-Marie-Tooth Syndrome: A systematic review of the literature. Medicine (Baltimore). 2016;95(17):e3278. Disponible en: https://doi.org/10.1097/MD.0000000000003278
45 Zivi I, Maffia S, Ferrari V, Zarucchi A, Molatore K, Maestri R et al. Effectiveness of aquatic versus land physiotherapy in the treatment of peripheral neuropathies: a randomized controlled trial. Clin Rehabil. 2018;32(5):663-670. Disponible en: https://doi.org/10.1177/0269215517746716
46. Van Thillo A, Vulsteke JB, Van Assche D, Verschueren P, De Langhe E. Physical therapy in adult inf lammatory myopathy patients: a systematic review. Clin Rheumatol. 2019;38:2039-2051. Disponible en: https://doi.org/10.1007/s10067-019-04571-9
47. Novak P, Šmid S, Vidmar G. Rehabilitation of Guillain-Barré syndrome patients: An observational study. Int J Rehabil Res. 2017;40(2):158-163. Disponible en: https://doi.org/10.1097/MRR.0000000000000225
48. Bartolo M, Intiso D, Lentino C, Sandrini G, Paolucci S, Zampolini M. et al. Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/ Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic. Front Neurol. 2020;11:423. Disponible en: https://doi.org/10.3389/fneur.2020.00423
49. Hollander JE, Carr BG.Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-1681. Disponible en: https://doi.org/10.1056/NEJMp2003539
50. Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A et al. Rehabilitation of patients post-Covid-19 infection: a literature review. J Int Med Res. 2020;48(8):300060520948382. Disponible en: https://doi.org/10.1177/0300060520948382
51. Choon H, Hoening H. How Should the Rehabilitation Community Prepare for 2019-nCoV. Arch. Phys. Med. Rehabil. 2020;101(6):1068-1071. Disponible en: https://doi.org/10.1016/j.apmr.2020.03.003
52. Chauhan V, Galwankar S, Arquilla B, Garg M, Somma S Di, El-Menyar A et al. Novel coronavirus (Covid-19): Leveraging telemedicine to optimize care while minimizing exposures and viral transmission. J Emerg Trauma Shock. 2020;13(1):20-24. Disponible en: https://doi.org/10.4103/jets.jets_32_20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32308272/
2. Organización Panamericana de la Salud [OPS] - Organización Mundial de la Salud [OMS]. Actualización epidemiológica: Enfermedad por coronavirus (Covid-19) - 26 de agosto de 2020 [Internet]. 2020 [citado 2020 junio 2020]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-enfermedad-porcoronavirus-covid-19-26-agosto-2020
3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (Covid19) outbreak. J Autoimmun. 2020;109:102433. Disponible en: http://doi.org/10.1016/j.jaut.2020.102433
4. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020;133(9):1015-1024. Disponible en: https://doi.org/10.1097/CM9.0000000000000722
5 Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (Covid-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. Disponible en: https://doi.org/10.1186/s40249-020-00646-xh
6. Yuki K, Fujiogi M, Koutsogiannaki S. Covid-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. Disponible en: https://doi.org/10.1016/j.clim.2020.108427
7. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T et al. The epidemiology and clinical information about Covid-19. Eur J Clin Microbiol Infect Dis. 2020; 39:1011-1019. Disponible en: https://doi.org/10.1007/s10096-020-03874-zht
8. World Health Organization [WHO]. WHO Coronavirus disease (Covid-19) dashboard [Internet]. 2020. [citado 2020 junio 21]. Disponible en: https://covid19.who.int
9. Tindale LC, Stockdale JE, Coombe M, Garlock ES, Yin W, Lau V et al. Evidence for transmission of Covid-19 priorto symptomonset. eLife. 2020;9:e57149.
Disponible en: https://doi.org/10.7554/eLife.57149ht
10. Zhang Y, Muscatello D, Tian Y, Chen Y, Li S, Duan W et al. Role of presymptomatic transmission of Covid-19: evidence from Beijing, China. J Epidemiol Community Health. 2020;0:1-4. Disponible en: https://doi.org/10.1136/jech-2020-214635
11. Viego V, Geri M, Castiglia J, Jouglard E. Período de incubación e intervalo serial para Covid-19 en una cadena de transmisión en Bahía Blanca (Argentina). Ciên Saúde Coletiva. 2020;25(9):3503-3510. Disponible en: https://doi.org/10.1590/1413-81232020259.20852020
12. Nikolai LA, Meyer CG, Kremsner PG, Velavan TP. Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible. Int J Infect Dis. 2020;100:112-116. Disponible en: https://doi.org/10.1016/j.ijid.2020.08.076ht
13. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H et al. An overview of Covid-19. J Zhejiang Univ Sci B. 2020;21:343-360. Disponible en: https://doi.org/10.1631/jzus.B2000083
14. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W et al. Virology, epidemiology, pathogenesis, and control of Covid-19. Viruses. 2020;12(4):372. Disponible en: https://doi.org/10.3390/v12040372
15. Vaninov N. In the eye of the Covid-19 cytokine storm. Nat Rev Immunol 2020;20:277. Disponible en: https://doi.org/10.1038/s41577-020-0305-6
16. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell infection and endotheliitis in Covid-19. Lancet. 2020;395(10234):1417-1418. Disponible en: https://doi.org/10.1016/S0140-6736(20)30937-5h
17. Cecconi M, Forni G, Mantovani A. Ten things we learned about Covid-19. Intensive Care Med. 2020;46:1590-1593. Disponible en: https://doi.org/10.1007/s00134-020-06140-0
18. Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini P et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the Covid-19 pandemic. J Neurol Sci. 2020;417:117085. Disponible en: https://doi.org/10.1016/j.jns.2020.117085
19. Javed B, Sarver A, Soto EB, Mashwani Z. The coronavirus (Covid-19) pandemic’s impacton mental health. Int J Health Plann Manage. 2020; 35(5):993-996. Disponible en: https://doi.org/10.1002/hpm.3008ht
20. Payus AO, Liew Sat Lin C, Mohd Noh M, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (Covid-19). Bosn J Basic Med Sci. 2020;20(3):283-292. Disponible en: https://doi.org/10.17305/bjbms.2020.4860
21. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F et al. Covid-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. Disponible en: https://doi.org/10.1111/joim.13091h
22. Lahiri D, Ardila A. Covid-19 Pandemic: A Neurological Perspective. Cureus. 2020;12(4): e7889. Disponible en: https://doi.org/10.7759/cureus.7889
23. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Disponible en: https://doi.org/10.1001/jamaneurol.2020.1127
24. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM et al. The neurology of Covid19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. Disponible en: https://doi.org/10.1016/j.jns.2020.116884
25. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2:
from neurological manifestations of Covid-19 to potential neurotropic mechanisms. J Neurol. 2020;267:2179-2184. Disponible en: https://doi.org/10.1007/s00415-020-09929-7
26. McNeary L, Maltser S, Verduzco-Gutierrez M. Navigating Coronavirus Disease 2019 (Covid-19) in Physiatry: A CAN Report for Inpatient Rehabilitation Facilities. PM&R. 2020;12(5): 512-515. Disponible en: https://doi.org/10.1002/pmrj.12369
27. Carda S, Invernizzi M, Bavikatte G, Bensmaïl D, Bianchi F, Deltombe T et al. Covid-19 pandemic. What should PRM specialists do? A clinician’s perspective. Eur J Phys Rehabil Med. 2020;56(4):515-524. Disponible en: https://doi.org/10.23736/S1973-9087.20.06317-0
28. Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T et al. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20:e00771. Disponible en:
https://doi.org/10.1016/j.idcr.2020.e00771ht
29. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-384. Disponible en: https://doi.org/10.1016/S1474-4422(20)30109-5ht
30. Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (Covid-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41:1351-1354. Disponible en: https://doi.org/10.1007/s10072-020-04449-8
31. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. Covid-19 may induce Guillain–Barré syndrome. Rev Neurol (Paris). 2020;176(6):516-518. Disponible en: https://doi.org/10.1016/j.neurol.2020.04.003ht
32. Sedaghat Z, Karimi N. Guillain-Barré syndrome associated with Covid-19 infection: A case report. J Clin Neurosci. 2020;76:233-235. Disponible en: https://doi.org/10.1016/j.jocn.2020.04.062
33. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARSCoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Sys. 2020;25:204- 207. Disponible en: https://doi.org/10.1111/jns.12382
34. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, GordoMañas R et al. Miller Fisher Syndrome and polyneuritis cranialis in Covid-19. Neurology. 2020;95(5):e607-e605. Disponible en: https://doi.org/10.1212/WNL.0000000000009619
35. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. Covid-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020; 95(5):221-223. Disponible en: https://doi.org/10.1212/WNL.0000000000009700
36. De Freitas Ferreira ACA, Romão TT, SIlva Macedo Y, Pupe C, Nascimento OJM. COVID?19 and herpes zoster co?infection presenting with trigeminal neuropathy. Eur J Neurol. 2020;27(9):1748- 1750. Disponible en: https://doi.org/10.1111/ene.14361
37. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. Disponible en: https://doi.org/10.1016/S0140-6736(20)30183-5ht
38. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. Disponible en: https://doi.org/10.1001/jama.2020.1585
39. Alexrescu R, Siegert RJ, Turner-Stokes L. Functional outcomes and efficiency of rehabilitation in a national cohort of patients with Guillain - Barré syndrome and other inf lammator y polyneuropathies. PLoS One. 2014; 9(11):e110532. Disponible en: https://doi.org/10.1371/journal.pone.0110532
40. Sheehy LM. Considerations for postacute rehabilitation for survivors of Covid-19. JMIR Public Health Surveill. 2020;6(2):e19462. Disponible en: https://doi.org/10.2196/19462
41. Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S et al. The Stanford Hall consensus statement for post-Covid-19 rehabilitation. Br J Sports Med. 2020; 54:949-959. Disponible en: https://doi.org/10.1136/bjsports-2020-102596
42. Turner-Stokes L, Vanderstay R, Stevermuer T, Simmonds F, Khan F, Eagar K. Comparison of rehabilitation outcomes for long term neurological conditions: A cohort analysis of the Australian rehabilitation outcomes centre dataset for adults of working age. PLoS One. 2015;10(7):e0132275. Disponible en: https://doi.org/10.1371/journal.pone.0132275
43. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15:671– 683. Disponible en: https://doi.org/10.1038/s41582-019-0250-9
44. Corrado B, Ciardi G, Bargigli C. Rehabilitation Management of the Charcot-Marie-Tooth Syndrome: A systematic review of the literature. Medicine (Baltimore). 2016;95(17):e3278. Disponible en: https://doi.org/10.1097/MD.0000000000003278
45 Zivi I, Maffia S, Ferrari V, Zarucchi A, Molatore K, Maestri R et al. Effectiveness of aquatic versus land physiotherapy in the treatment of peripheral neuropathies: a randomized controlled trial. Clin Rehabil. 2018;32(5):663-670. Disponible en: https://doi.org/10.1177/0269215517746716
46. Van Thillo A, Vulsteke JB, Van Assche D, Verschueren P, De Langhe E. Physical therapy in adult inf lammatory myopathy patients: a systematic review. Clin Rheumatol. 2019;38:2039-2051. Disponible en: https://doi.org/10.1007/s10067-019-04571-9
47. Novak P, Šmid S, Vidmar G. Rehabilitation of Guillain-Barré syndrome patients: An observational study. Int J Rehabil Res. 2017;40(2):158-163. Disponible en: https://doi.org/10.1097/MRR.0000000000000225
48. Bartolo M, Intiso D, Lentino C, Sandrini G, Paolucci S, Zampolini M. et al. Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/ Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic. Front Neurol. 2020;11:423. Disponible en: https://doi.org/10.3389/fneur.2020.00423
49. Hollander JE, Carr BG.Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-1681. Disponible en: https://doi.org/10.1056/NEJMp2003539
50. Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A et al. Rehabilitation of patients post-Covid-19 infection: a literature review. J Int Med Res. 2020;48(8):300060520948382. Disponible en: https://doi.org/10.1177/0300060520948382
51. Choon H, Hoening H. How Should the Rehabilitation Community Prepare for 2019-nCoV. Arch. Phys. Med. Rehabil. 2020;101(6):1068-1071. Disponible en: https://doi.org/10.1016/j.apmr.2020.03.003
52. Chauhan V, Galwankar S, Arquilla B, Garg M, Somma S Di, El-Menyar A et al. Novel coronavirus (Covid-19): Leveraging telemedicine to optimize care while minimizing exposures and viral transmission. J Emerg Trauma Shock. 2020;13(1):20-24. Disponible en: https://doi.org/10.4103/jets.jets_32_20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32308272/
Cómo citar
1.
Labrador Jiménez JS, McCormick Useche LE, Muñoz Rodríguez MC, Jaramillo Gómez NA, Guerrero Cardozo LP, Flórez Puentes LN, et al. Manifestaciones neurológicas periféricas en la infección por Sars-CoV-2: enfoque desde la Medicina Física y la Rehabilitación. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 25 de septiembre de 2020 [citado 18 de abril de 2024];30(Supl):62-75. Disponible en: https://revistacmfr.org/index.php/rcmfr/article/view/255
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2020-09-25
Número
Sección
Revisión sistemática
